When I made the following post on Monday the last price for CST was $3.23.
Closed today at $2.96.
Still a healthy clip above the placement price of $2.40 but does demonstrate how issues substantially below market can destroy a share price (for a while at least).
Even more disappointing is the fact CST last traded at $3.18 BEFORE they received FDA approval.
Hard to see the decline stopping before either (a) it does hit $2.40 or (b) they get Japanese approval.
CST Price at posting:
0.0¢ Sentiment: None Disclosure: Held